Total Payments
$4,649
2024 Payments
$424.13
Companies
13
Transactions
63
Medicare Patients
7,872
Medicare Billing
$548,507
Payment Breakdown by Category
Food & Beverage$3,651 (78.5%)
Consulting$900.00 (19.4%)
Education$97.99 (2.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,651 | 61 | 78.5% |
| Consulting Fee | $900.00 | 1 | 19.4% |
| Education | $97.99 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | $1,349 | 8 | $0 (2024) |
| ABBVIE INC. | $739.49 | 23 | $0 (2024) |
| Alcon Laboratories Inc | $711.07 | 7 | $0 (2018) |
| Iridex Corporation | $663.94 | 3 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $387.60 | 6 | $0 (2022) |
| Glaukos Corporation | $168.80 | 1 | $0 (2023) |
| Alcon Vision LLC | $131.24 | 6 | $0 (2023) |
| Aveo Pharmaceuticals, Inc. | $120.74 | 1 | $0 (2021) |
| Allergan Inc. | $97.99 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $97.08 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $424.13 | 15 | ABBVIE INC. ($241.28) |
| 2023 | $1,470 | 20 | Iridex Corporation ($620.16) |
| 2022 | $1,616 | 13 | Bausch & Lomb Americas Inc. ($1,181) |
| 2021 | $204.06 | 5 | Aveo Pharmaceuticals, Inc. ($120.74) |
| 2019 | $28.47 | 1 | Johnson & Johnson Vision Care, Inc. ($28.47) |
| 2018 | $711.07 | 7 | Alcon Laboratories Inc ($711.07) |
| 2017 | $195.07 | 2 | Allergan Inc. ($97.99) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO, LOTEMAX SM | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.98 | General |
| Category: EYE CARE | ||||||
| 11/07/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $2.15 | General |
| Category: EYE CARE | ||||||
| 10/23/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: EYE CARE | ||||||
| 10/22/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $33.77 | General |
| Category: EYE CARE | ||||||
| 09/18/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Ophthalmology | ||||||
| 07/31/2024 | Iridex Corporation | — | Food and Beverage | Cash or cash equivalent | $43.78 | General |
| 07/31/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: EYE CARE | ||||||
| 07/02/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: EYE CARE | ||||||
| 06/14/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: EYE CARE | ||||||
| 04/30/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $34.30 | General |
| Category: EYE CARE | ||||||
| 04/11/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $123.41 | General |
| Category: EYE CARE | ||||||
| 03/20/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Ophthalmology | ||||||
| 03/14/2024 | Penumbra, Inc. | RED 72 (Device) | Food and Beverage | Cash or cash equivalent | $74.47 | General |
| Category: Neurointervention | ||||||
| 01/31/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $6.14 | General |
| Category: EYE CARE | ||||||
| 12/06/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Ophthalmology | ||||||
| 11/16/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $168.80 | General |
| 11/10/2023 | Bausch & Lomb Americas Inc. | IC-8 Apthera IOL (Device), enVista MX60 IOL | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Ophthalmology | ||||||
| 11/09/2023 | ABBVIE INC. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $5.84 | General |
| Category: EYE CARE | ||||||
| 10/30/2023 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: EYE CARE | ||||||
| 09/27/2023 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $117.12 | General |
| Category: EYE CARE | ||||||
| 09/06/2023 | ABBVIE INC. | ALPHAGAN P (Drug), LUMIGAN | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: EYE CARE | ||||||
| 07/31/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: EYE CARE | ||||||
| 07/26/2023 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: EYE CARE | ||||||
| 07/06/2023 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 3,469 | 4,085 | $709,883 | $249,057 |
| 2022 | 16 | 3,280 | 3,827 | $631,090 | $222,394 |
| 2021 | 12 | 1,123 | 1,193 | $181,190 | $77,056 |
Total Patients
7,872
Total Services
9,105
Medicare Billing
$548,507
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 485 | 958 | $162,860 | $84,496 | 51.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 502 | 596 | $83,580 | $25,941 | 31.0% |
| 92273 | Measurement of retinal and optic nerve function | Office | 2023 | 264 | 266 | $66,500 | $25,220 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 187 | 187 | $48,620 | $21,449 | 44.1% |
| 65820 | Incision to improve eye fluid flow | Facility | 2023 | 15 | 21 | $25,158 | $13,555 | 53.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 158 | 159 | $30,210 | $13,260 | 43.9% |
| 95930 | Measurement of nerve conduction using visual stimulation testing with report | Office | 2023 | 258 | 259 | $69,930 | $13,191 | 18.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 373 | 378 | $30,240 | $9,768 | 32.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 464 | 478 | $28,680 | $9,717 | 33.9% |
| 92250 | Photography of the retina | Office | 2023 | 267 | 268 | $34,840 | $6,893 | 19.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 77 | 82 | $10,660 | $4,922 | 46.2% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 14 | 21 | $77,700 | $4,866 | 6.3% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 20 | 25 | $14,000 | $4,536 | 32.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 32 | $7,200 | $4,364 | 60.6% |
| 92134 | Imaging of retina | Office | 2023 | 148 | 149 | $11,920 | $4,335 | 36.4% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 176 | 176 | $3,520 | $1,471 | 41.8% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 17 | 17 | $2,380 | $598.36 | 25.1% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 13 | 13 | $1,885 | $473.75 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 501 | 907 | $154,190 | $76,428 | 49.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 509 | 605 | $84,700 | $26,409 | 31.2% |
| 92273 | Measurement of retinal and optic nerve function | Office | 2022 | 214 | 215 | $53,740 | $20,976 | 39.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 228 | 230 | $43,700 | $19,870 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 158 | 158 | $41,080 | $18,775 | 45.7% |
| 95930 | Measurement of nerve conduction using visual stimulation testing with report | Office | 2022 | 209 | 210 | $56,700 | $10,857 | 19.1% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 453 | 469 | $28,140 | $9,469 | 33.7% |
About Varun Reddy
Varun Reddy is a Glaucoma Specialist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2016. The National Provider Identifier (NPI) number assigned to this provider is 1013361484.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Varun Reddy has received a total of $4,649 in payments from pharmaceutical and medical device companies, with $424.13 received in 2024. These payments were reported across 63 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($3,651).
As a Medicare-enrolled provider, Reddy has provided services to 7,872 Medicare beneficiaries, totaling 9,105 services with total Medicare billing of $548,507. Data is available for 3 years (2021–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Glaucoma Specialist
- Location New York, NY
- Active Since 04/21/2016
- Last Updated 03/31/2020
- Taxonomy Code 207WX0009X
- Entity Type Individual
- NPI Number 1013361484
Products in Payments
- VYZULTA (Drug) $1,225
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $555.74
- AcrySof (Device) $388.47
- Kerendia (Drug) $373.99
- ACTIVEFOCUS (Device) $277.74
- IC-8 Apthera IOL (Device) $124.74
- FOTIVDA (Drug) $120.74
- XARELTO (Drug) $97.08
- LUMIGAN (Drug) $93.57
- RED 72 (Device) $74.47
- DURYSTA (Drug) $56.74
- Simbrinza (Drug) $48.18
- Centurion (Device) $44.86
- OMNI SURGICAL SYSTEM (Device) $41.41
- OMNI(R) SURGICAL SYSTEM (US) (Device) $37.72
- ARGOS (Device) $37.10
- ALPHAGAN P (Drug) $33.44
- Rocklatan (Drug) $24.74
- Clareon (Device) $21.22
- Stivarga (Drug) $13.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Glaucoma Specialist Doctors in New York
Jeffrey Liebmann, Md, MD
Glaucoma Specialist — Payments: $175,452
Glaucoma Specialist $175,452
Sarah Vantassel, Md, MD
Glaucoma Specialist — Payments: $66,165
Glaucoma Specialist $66,165
Dr. Yuna Rapoport, M.d, M.D
Glaucoma Specialist — Payments: $50,022
Glaucoma Specialist $50,022
Aakriti Shukla, M.d, M.D
Glaucoma Specialist — Payments: $41,163
Glaucoma Specialist $41,163
Dr. Sonya Dhar, Md, MD
Glaucoma Specialist — Payments: $20,404
Glaucoma Specialist $20,404
Luis Silva Alvarez, M.d, M.D
Glaucoma Specialist — Payments: $7,831
Glaucoma Specialist $7,831